Greetings from Hetero Labs Limited. We are conducting a walk-in interview for positions in OSD Production and Quality Control on March 1st, 2025. This is an excellent opportunity for individuals passionate about quality, safety, and production within the pharmaceutical sector to join a prominent team. The available positions are in the Production and Quality Control departments, located in Jadcherla, Hyderabad. Candidates with 1 to 7 years of relevant experience and qualifications such as ITI, Diploma, B.Sc., B.Pharmacy, or M.Sc. are encouraged to apply. Specific roles include Production in Compression, Coating, Capsule Filling, and Granulation, as well as Packing in Blister and Bottle Packing, and Quality Control involving HPLC, GC, IP, FP, LCMS, and ICPMS.
We are hiring for following positions
Department: Production/ Quality Control
Experience Required: 01 to 07 Years of Relevance Experience
Qualification: ITI/ Diploma/ B.Sc./ B. Pharmacy/ M.Sc.
Work Location: Jadcherla, Hyderabad.
Job Description:
- Production – Coating/ Compression/ Capsule Filling/ Granulation
- Packing- Bottle Packing/ Blister Packing
- Quality Control ā HPLC/ GC/ LCMS/ ICPMS/ IP/ FP
Walk-in Interview Details:
Date of interview: 1st March 2025
Time: 09:00 AM ā 3:00 PM
Venue: Kritunga Restaurant & Banquet Hall Jadcherla, 1st Floor, Above Reliance Smart, Opposite New Bus Stand, Jadcherla, Mahabubnagar – 509301.
š Contact: 9010203989 | prashanthkumar.v@hetero.com
Why Join Us?
- Attractive remuneration and comprehensive benefits package š¼
- Opportunities for professional development and advancement š
- A vibrant and cooperative workplace environment š
- Join a prominent pharmaceutical organization with a worldwide influence š
Documents Required
- Latest Updated Resume
- Educational Certificates
- Previous Employment Documents (if applicable)
- Photo ID
About Hetero Labs Limited
Hetero is an Indian pharmaceutical company known for being the world’s largest producer of anti-retroviral drugs and for launching generic medications, including the first generic version of the Remdesivir injection, COVIFOR, used in the treatment of COVID-19. The company specializes in providing active pharmaceutical ingredients (APIs) and generic formulations.